Market

UnitedHealth Shares Plunge 20% in Premarket Following Grim Forecast and Rising Costs

UnitedHealth Faces Challenges Amid Rising Costs

UnitedHealth Group Inc. experienced a dramatic 20% drop in premarket trading this Thursday. This significant decline comes after the company revised its forecast downward in its first quarter 2025 earnings report, highlighting increasing costs associated with a surge in medical care among older adults.

Leadership Responds to Challenges

CEO Andrew Witty addressed the situation, stating that while UnitedHealth has expanded its coverage to include more people and services, it has not met its targets. Witty emphasized the company's commitment to taking corrective actions to steer towards future growth.

Regulatory Scrutiny and Tragic Loss

The company is also under the microscope for its Medicare Advantage billing practices, with a Senate committee launching an inquiry over potential fraud concerns. In a separate tragic event, UnitedHealthcare CEO Brian Thompson was fatally shot in a targeted attack outside a Manhattan hotel last December, with the suspect now facing murder charges and the possibility of the death penalty.

At 6:30 am ET, UnitedHealth's shares were down 20.26%, trading at $465.60.